Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder

被引:0
作者
Gaca, Zuzanna [1 ]
Pruc, Michal [1 ,2 ]
Swieczkowski, Damian [1 ,3 ]
Kwasny, Aleksander [4 ]
Szarpak, Lukasz [1 ,5 ,6 ]
Cubala, Wies law J. [4 ]
机构
[1] LUXMED Grp, Dept Clin Res & Dev, PL-02676 Warsaw, Poland
[2] Int European Univ, Dept Publ Hlth, Kiev, Ukraine
[3] Med Univ Gdansk, Fac Pharm, Dept Toxicol, Gdansk, Poland
[4] Med Univ Gdansk, Fac Med, Dept Psychiat, Gdansk, Poland
[5] Baylor Coll Med, Henry JN Taub Dept Emergency Med, Houston, TX USA
[6] Maria Sklodowska Curie Bialystok Oncol Ctr, Bialystok, Poland
关键词
AXS-05; Auvelity; Dextromethorphan-bupropion; Depression; Major depressive disorder;
D O I
10.1016/j.euroneuro.2024.04.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:18 / 19
页数:2
相关论文
共 4 条
[1]   Prevalence and correlates of major depressive disorder: a systematic review [J].
Gutierrez-Rojas, Luis ;
Porras-Segovia, Alejandro ;
Dunne, Henry ;
Andrade-Gonzalez, Nelson ;
Cervilla, Jorge A. .
BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) :657-672
[2]   Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI) [J].
Iosifescu, Dan V. ;
Jones, Amanda ;
O'Gorman, Cedric ;
Streicher, Caroline ;
Feliz, Samantha ;
Fava, Maurizio ;
Tabuteau, Herriot .
JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (04)
[3]   Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial [J].
Tabuteau, Herriot ;
Jones, Amanda ;
Anderson, Ashley ;
Jacobson, Mark ;
Iosifescu, Dan, V .
AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (07) :490-499
[4]  
Witkin JM, 2019, ADV PHARMACOL, V86, P47, DOI 10.1016/bs.apha.2019.03.002